We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

98 hedge funds and large institutions have $306M invested in GenMark Diagnostics, Inc in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $239M → $306M (+$66.8M)

14% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 29

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

1% less funds holding

Funds holding: 99 → 98 (-1)

Holders
98
Holders Change
-1
Holders Change %
-1.01%
% of All Funds
2.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
33
Reduced
29
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
+$5.57M
2
BG
Bellevue Group
Switzerland
+$2.05M
3
PI
Putnam Investments
Massachusetts
+$1.65M
4
PWP
Private Wealth Partners
California
+$1.49M
5
BCM
Bridgeway Capital Management
Texas
+$894K

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$7.57M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.48M
3
Millennium Management
Millennium Management
New York
-$2.7M
4
GTC
Ghost Tree Capital
New York
-$2.08M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
26
Federated Hermes
Pennsylvania
$1.09M – – –
WMSA
27
Weiss Multi-Strategy Advisers
New York
$1.09M +$244K +49,000 +32%
Jennison Associates
28
Jennison Associates
New York
$1.05M -$7.57M -1,523,556 -89%
NIM
29
Needham Investment Management
New York
$979K – – –
BCM
30
Bridgeway Capital Management
Texas
$979K +$894K +179,900 New
TD Asset Management
31
TD Asset Management
Ontario, Canada
$972K +$20.4K +4,100 +2%
TCIM
32
TIAA CREF Investment Management
New York
$910K -$41.5K -8,356 -5%
Russell Investments Group
33
Russell Investments Group
United Kingdom
$848K +$24.4K +4,903 +3%
ARTA
34
A.R.T. Advisors
New York
$708K +$398K +80,024 +159%
TA
35
Teachers Advisors
New York
$679K -$2.34K -470 -0.4%
Two Sigma Advisers
36
Two Sigma Advisers
New York
$630K -$161K -32,400 -22%
Two Sigma Investments
37
Two Sigma Investments
New York
$617K -$1.6M -322,559 -74%
RA
38
Royce & Associates
New York
$562K +$186K +37,500 +57%
William Blair & Company
39
William Blair & Company
Illinois
$524K +$14.9K +3,000 +3%
Swiss National Bank
40
Swiss National Bank
Switzerland
$484K – – –
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$429K -$11.3K -2,281 -3%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$395K +$249K +50,009 +222%
Deutsche Bank
43
Deutsche Bank
Germany
$393K -$219K -44,003 -38%
DCM
44
Donaldson Capital Management
Indiana
$370K – – –
Citadel Advisors
45
Citadel Advisors
Florida
$358K -$73.6K -14,816 -18%
Millennium Management
46
Millennium Management
New York
$331K -$2.7M -543,217 -90%
FC
47
Fairpointe Capital
Illinois
$286K – – –
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$276K – – –
FA
49
FDx Advisors
Illinois
$275K -$15.3K -3,069 -6%
UBS AM
50
UBS AM
Illinois
$269K – – –
1
2
3 4 5

GNMK Hedge Fund Activity: Q1 2018 in Review

98 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2018, worth a combined $306M — up 28% from $239M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of GNMK and 11 opened new positions — a net loss of 1 holder — while 29 trimmed existing stakes and 33 added.

The largest buyer was Casdin Capital, adding an estimated $5.57M. The largest seller was Jennison Associates, cutting an estimated $7.57M.

  • 98 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2018, down from 99 in Q4 2017.
  • Funds reported $306M of GenMark Diagnostics, Inc stock for Q1 2018, up 28% quarter-over-quarter.
  • 11 funds opened new GenMark Diagnostics, Inc positions in Q1 2018 and 12 closed out, a net change of -1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q1 2018 was Casdin Capital, an estimated $5.57M added.
  • The largest GenMark Diagnostics, Inc seller in Q1 2018 was Jennison Associates, an estimated $7.57M sold.

Based on aggregated 13F filings for Q1 2018.